Barriers to uptake of antenatal maternal screening tests in Senegal

listen audio

Study Justification:
The study aimed to identify barriers to the uptake of antenatal maternal screening tests in Senegal. This is important because evidence shows that these tests can contribute to the reduction of maternal morbidity and mortality. However, there is a lack of data on the coverage of the complete set of recommended tests. By understanding the barriers, efforts can be made to increase test uptake and improve maternal and infant health outcomes.
Highlights:
– Only 13% of community women and 22% of women in the lab had received the complete set of tests recommended by the Ministry of Health in Senegal.
– 38% of community women who visited antenatal care facilities did not access a laboratory due to various social, financial, and antenatal care-related reasons.
– The lowest test uptake was observed in women receiving antenatal care at health posts.
– Barriers at the laboratory level included the cost of the test, stock-outs of reagents, and broken equipment.
– Midwives were the main gatekeepers of the laboratory and did not request all tests due to assumptions about women’s financial problems and reliance on clinical symptoms.
Recommendations:
– Provide accessible testing guidelines to increase awareness and understanding of the importance of antenatal maternal screening tests.
– Reduce the cost of tests to make them more affordable and accessible to all women.
– Raise awareness about the reasons for tests to address misconceptions and increase acceptance.
– Make the complete test set available in point-of-care format in peripheral health posts to improve access for women receiving antenatal care in these settings.
– National and international antenatal care policies and programs should prioritize and facilitate access to maternal screening tests to contribute to the reduction of maternal and infant morbidity and mortality.
Key Role Players:
– Ministry of Health in Senegal
– ANC and laboratory personnel
– Directors and social workers at health facilities
– Medical directors
– Health committee members
Cost Items for Planning Recommendations:
– Development and dissemination of accessible testing guidelines
– Cost reduction strategies for tests
– Awareness campaigns and educational materials
– Point-of-care testing equipment and supplies for peripheral health posts
– Training and capacity building for ANC and laboratory personnel
– Coordination and monitoring of antenatal care policies and programs

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study collected data from multiple sources, including communities, antenatal care clinics, and laboratories across Senegal. Mixed-methods were used, including ethnography, in-depth interviews, and workshops. The study identified barriers to uptake of antenatal maternal screening tests and provided recommendations to improve test uptake. However, the abstract does not provide information on the sample size or representativeness of the study population. Additionally, the abstract does not mention any statistical analysis conducted on the data. To improve the strength of the evidence, the study could include a larger sample size and conduct statistical analysis to support the findings.

Background Evidence exists that selective antenatal maternal screening tests contribute to the reduction of maternal morbidity and mortality. However, data are lacking on coverage with the complete set of recommended tests. The study aimed to identify barriers to uptake of the complete set of tests recommended by the Ministry of Health in Senegal. Methods Data were collected in communities, antenatal care (ANC) clinics and the laboratories of 11 public health care facilities across Senegal. Mixed-methods included ethnography (observations and informal conversations), in-depth interviews and workshops at the health facilities; structured interviews with 283 women receiving antenatal tests (“women in the lab”); in-depth interviews with 81 women in communities who were pregnant or had recently delivered (“community women”). Results Only 13% of community women and 22% of women in the lab had received the complete set of tests. For various social, financial and antenatal care-related reasons 38% of community women who visited antenatal care facilities did not access a laboratory. The lowest test uptake was in women receiving antenatal care at health posts. Barriers at the laboratory level were the cost of the test, stock-outs of reagents, and broken equipment. Midwives were the main gatekeepers of the laboratory, not requesting (all) tests because of assumptions about women’s financial problems and reliance on clinical symptoms. Conclusion In Senegal, recommended antenatal maternal screening tests are substantially underutilized. Efforts to increase test uptake should include accessible testing guidelines, reducing the cost of tests, raising awareness about the reasons for tests, and making the complete test set in point-of-care format accessible in peripheral health posts. National and international antenatal care policies and programs should facilitate access to maternal screening tests as a contribution to reducing maternal and infant morbidity and mortality.

Study sites were located in and around three hospitals and eight health centers across Senegal; three sites in Dakar and eight outside Dakar (“in the region”’). Eleven of a total of 96 public health facilities hosting a laboratory (the intermediate tiers of the health care delivery system), were purposefully sampled to cover the 14 administrative regions. At the health facilities, study populations included all ANC and laboratory personnel, and other relevant staff (including directors and social workers). At community/client level the two study populations comprised (i) in communities: pregnant women and women who had delivered in the previous six months – later referred as ‘community women’ and (ii) in the laboratory: pregnant women who came for testing – later referred as ‘women in the lab’. Community women (81) were recruited by the local interpreters from across the facilities’ catchment areas. In the laboratories, we recruited as many women as possible coming for testing to the laboratory totaling 283 women in the lab (Table 1). Data collection methods, sample size, by study population and by level. Data were collected from February 2013 to July 2014. During the initial Phase One in four facilities, the fieldwork took six weeks to explore the factors influencing utilization and non-utilization of maternal screening, terminology, sensitivities in phrasing questions and approaching people, and key stakeholders. Phase Two was conducted in the seven remaining sites for a duration of one week per site. In health facilities, focusing on the ANC clinic and the laboratory, the main data collection method was ethnography, entailing participant observation, involving the observation of daily routines and informal conversations with staff and clients. The focus was on the organization and practice of services, work conditions, interactions, test requests, and available assays. In addition, in-depth interviews (IDI) were conducted with in-charges (IC) or senior staff of ANC and laboratories, and medical directors, health committee members, and social workers. During these IDIs we discussed the material and human resources in the facility and specifically for ANC and laboratory, the coordination between ANC and laboratory, their view of ANC and laboratory services’ quality and barriers to utilization of ANC testing. In Phase Two a four-hour workshop was organized in each facility with all laboratory and maternity staff, and other relevant staff, after piloting this method in the last health facility of Phase One. Participants worked in groups to identify and discuss the local barriers to test uptake at community, ANC and laboratory level, and to formulate area-specific solutions. At community/client level, in Phase One, we conducted 1–2 hour IDIs with women in their homes, often with family members participating – assisted by a local interpreter. These interviews solicited personal experiences with ANC and tests and information on their socio-demographic and economic background including family composition, and living conditions – the latter were also observed. The women in the lab were interviewed using a structured interview tool. These provided quantitative information on test requests by type of ANC provider, test execution, decision making on accessing the laboratory including paying for services and transportation, as well as information on socio-demographic and economic characteristics of women, and their experiences with services (Table 1). Daily fieldwork reports were written and the audio-recorded IDIs and workshop group-presentations were transcribed. These were analyzed using QSR International’s NVivo 10 software. The thematic data analysis was ongoing during the fieldwork. Starting from a list of themes, developed after the first weeks of fieldwork, the upcoming themes and concepts were added and explored in subsequent observations, conversations and IDIs. The data collected through the structured interviews were entered and analyzed in EpiData software. These data mainly serve descriptive purposes; statistical analysis was only carried out for Table 4 using Stata 12. Tests requested/done as POC, among women in the lab, by place for ANC. Ethical clearance for the SociaLab proposal SEN12/09 was granted by the Comité National d’Ethique pour la Recherche en Santé in Senegal. All individual participants were informed about the nature and purpose of the study and gave oral consent. In the community all women we approached cooperated in the interview, although two did not agree to audio-recording. At the laboratory three women refused to be interviewed.

Based on the provided information, here are some potential innovations that could improve access to maternal health in Senegal:

1. Accessible Testing Guidelines: Develop and distribute clear and easy-to-understand guidelines for antenatal maternal screening tests. These guidelines should be available in multiple languages and formats to ensure accessibility for all women.

2. Cost Reduction: Work towards reducing the cost of antenatal screening tests. This could involve negotiating lower prices with suppliers, exploring partnerships with organizations that can provide subsidies or financial assistance, or advocating for government funding to cover the cost of tests.

3. Awareness Campaigns: Launch targeted awareness campaigns to educate women and their families about the importance of antenatal screening tests. These campaigns should address common misconceptions and provide information on the benefits of early detection and treatment.

4. Point-of-Care Testing: Make the complete set of antenatal screening tests available in point-of-care format at peripheral health posts. This would eliminate the need for women to travel to larger healthcare facilities and reduce barriers related to transportation and distance.

5. Strengthening Laboratory Infrastructure: Address the issues of stock-outs of reagents and broken equipment in laboratories. This could involve regular monitoring of supplies, improving procurement processes, and providing training and resources to laboratory staff to ensure proper maintenance of equipment.

6. Training for Midwives: Provide training and support for midwives to ensure they are knowledgeable about the importance of all antenatal screening tests and are equipped to request and administer them. This would help overcome assumptions about women’s financial problems and reliance on clinical symptoms.

These innovations, if implemented effectively, could help improve access to maternal health services and increase the uptake of antenatal screening tests in Senegal.
AI Innovations Description
Based on the description provided, here is a recommendation that can be developed into an innovation to improve access to maternal health:

Develop a mobile health (mHealth) application that provides accessible testing guidelines and information about the recommended antenatal maternal screening tests in Senegal. The application should include details about the importance of each test, the reasons for conducting them, and the potential benefits for maternal and infant health. It should also provide information on the nearest health facilities offering the tests and their contact information.

The mHealth application should also address the financial barriers by providing information on the cost of each test and any available subsidies or financial assistance programs. It should include a feature that allows women to calculate the estimated cost of the complete set of tests based on their income level and provide options for payment plans or assistance.

To address the issue of stock-outs of reagents and broken equipment, the application can include real-time updates on the availability of tests at different health facilities. This can help women plan their visits to facilities where the tests are readily available.

Additionally, the mHealth application can provide educational resources and raise awareness about the importance of antenatal maternal screening tests through interactive content, videos, and testimonials from women who have benefited from the tests. This can help dispel any misconceptions or fears that women may have and encourage them to prioritize their health and the health of their babies.

To make the complete test set more accessible, the application can collaborate with peripheral health posts to offer point-of-care testing. This would eliminate the need for women to travel long distances to larger health facilities and reduce the financial burden associated with transportation costs.

Overall, the development of a comprehensive mHealth application can help overcome the barriers identified in the study and improve access to maternal health services in Senegal.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations for improving access to maternal health in Senegal:

1. Develop accessible testing guidelines: Create clear and easy-to-understand guidelines for antenatal maternal screening tests that are readily available to healthcare providers and pregnant women. These guidelines should outline the importance of each test and provide step-by-step instructions for conducting and interpreting the tests.

2. Reduce the cost of tests: Work towards reducing the cost of antenatal maternal screening tests to make them more affordable for pregnant women. This could involve negotiating lower prices with suppliers, exploring options for government subsidies, or seeking partnerships with organizations that can provide financial assistance.

3. Raise awareness about the reasons for tests: Conduct awareness campaigns to educate pregnant women and their families about the importance of antenatal maternal screening tests. Emphasize the potential benefits of early detection and intervention in reducing maternal and infant morbidity and mortality.

4. Make the complete test set accessible in peripheral health posts: Ensure that all necessary equipment and supplies for conducting the complete set of recommended tests are available in peripheral health posts. This will help overcome the barrier of having to travel to larger healthcare facilities for testing.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the indicators: Identify specific indicators that will be used to measure the impact of the recommendations. For example, indicators could include the percentage of pregnant women receiving the complete set of tests, the average cost of tests, and the level of awareness among pregnant women about the reasons for tests.

2. Collect baseline data: Gather data on the current status of access to maternal health services, including the uptake of antenatal maternal screening tests, the cost of tests, and the level of awareness among pregnant women. This can be done through surveys, interviews, and data analysis.

3. Implement the recommendations: Roll out the recommended interventions, such as developing accessible testing guidelines, reducing the cost of tests, raising awareness, and ensuring availability of testing equipment in peripheral health posts.

4. Monitor and evaluate: Continuously monitor the implementation of the recommendations and collect data on the selected indicators. This can be done through regular surveys, interviews, and data analysis.

5. Analyze the data: Analyze the collected data to assess the impact of the recommendations on improving access to maternal health. Compare the baseline data with the data collected after the implementation of the recommendations to determine any changes or improvements.

6. Adjust and refine: Based on the findings of the data analysis, make any necessary adjustments or refinements to the recommendations. This could involve scaling up successful interventions, addressing any challenges or barriers that were identified, and further optimizing the strategies for improving access to maternal health.

By following this methodology, it will be possible to simulate the impact of the recommendations on improving access to maternal health in Senegal and make evidence-based decisions for further interventions.

Yabelana ngalokhu:
Facebook
Twitter
LinkedIn
WhatsApp
Email